Charles Explorer logo
🇬🇧

Bleeding in portal hypertension

Publication at Faculty of Medicine in Hradec Králové |
2020

Abstract

Liver cirrhosis is the most common reason of clinically significant portal hypertension in the western countries. Portal vein or hepatic veins thrombosis is less common.

Variceal bleeding is the most severe life threatening complication of portal hypertension. Appropriate treatment includes initial general management, fluid replacement and hemosubstitution, anti- biotic prophylaxis, vasoactive medication and endoscopic treatment.

Transjugular intrahepatic portosystemic shunt (TIPS) is standard option in case of first line treatment failure. Dedicated esophageal metal stent or balloon tamponade could be used as a bridge to the TIPS or in case of TIPS contraindication.

Non selective beta-blockers and endoscopic therapy are used in primary and secondary prophylaxis.